Development and Characterization of Pharmaceutical Systems Containing Rifampicin
Antonella V. Dan Córdoba,
Virginia Aiassa,
Jesica A. Dimmer,
Camila N. Barrionuevo,
Mario A. Quevedo,
Marcela R. Longhi,
Ariana Zoppi
Affiliations
Antonella V. Dan Córdoba
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Virginia Aiassa
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Jesica A. Dimmer
Centro de Investigaciones y Transferencia de Villa María (CIT-VM), Universidad de Villa María, Villa María, Córdoba 5900, Argentina
Camila N. Barrionuevo
Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis, Facultad Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Mario A. Quevedo
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Marcela R. Longhi
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Ariana Zoppi
Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
Rifampicin is a potent antimicrobial drug with some suboptimal properties, such as poor stability, low solubility, and variable bioavailability. Therefore, in the current study, a multicomponent complex between rifampicin, γ-cyclodextrin, and arginine was prepared with the aim of improving drug properties. Solubility was evaluated by phase-solubility studies. The mechanism of interaction was established through proton nuclear magnetic resonance spectroscopy and molecular modeling. Physicochemical characterization was investigated using Fourier transform-infrared spectroscopy, powder X-ray diffraction, and scanning electron microscopy. The dissolution properties, antimicrobial activity (antibacterial, antibiofilm, and antileishmanial), and stability of the different samples were studied. The results obtained in this investigation demonstrate that multicomponent complexes can improve the water solubility and dissolution rate of rifampicin, as well as its antibacterial and antileishmanial action, and present suitable stability. In conclusion, rifampicin complexed with γ-cyclodextrin and arginine is an attractive approach for developing pharmaceutical dosage forms of rifampicin with increased antimicrobial activities.